In renal cell carcinoma (RCC), METTL5 was significantly overexpressed in both clear cell RCC (KIRC) and papillary RCC (KIRP), correlating with tumor stage, grade, and poor prognosis. The gene discussed is METTL5; the disease is neoplasm.